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ABSTRACT  
In Ayurveda, it is described that Viruddha aahar is the main etiological factor for so many diseases. 
Shvitra is one of them. This study focuses to develop evidence based support for efficacy of textual 
reference of Yogaratnakara regarding Shvitraghna property of Shashilekha Vati with Bakuchi tail and 
Madhu as Anupana with special reference to vitiligo. Shashilekha Vati was prepared according to the 
method mentioned in the classical text of Yogaratnakara. The trial was conducted on a sample size of 60 
divided in two groups. In the criteria of assessment, measurement of area of lesion, nature of 
regimentation and degree of regimentation were taken. It is observed that there is significant 
regimentation in the treated lesion and reduction in total area of lesions.  
Shashilekha Vati with Anupana enters to all Sukshmastrotasas and it acts on dash, Dhatu by properties of 
Sukshma, Tikshna guna and Ushna virya. Thus it does Diana, patina and acts as Tayca, Varna. Oil of 
Bakunin acts on arterioles of sub capillary plexus due to which they dilate and increase the plasma in 
this area. At the same time copper acts on enzyme tyrosines. Due to which melanoblasts are stimulated. 
They further exude and diffuse into the decolourised area and pigmentation takes place in that area. It is 
observed that out of 30 patients in Drug Group i.e. taking Shashilekha Vati, 19 patients had marked to 
complete (76-100%) regimentation, 7 patients had marked (51-75%) regimentation, 3 patients had 
moderate (26-50%) regimentation and only one patient had minimal (below 25%) regimentation. The 
Drug in Group A-Shashilekha Vati showed significant regimentation and reduction in area of lesions as 
compared to Group B. 
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INTRODUCTION 
Today’s fastly developing world has made man 
to compete for a decent economical status. In order to 
achieve that man has to adopt constantly busy and fast 
life style which has its own sequels like constant 
physical and mental stress, tensions etc. This life style 
has much impact on the health of man. This busy life 
style is supplemented by changing food habits. Food, 
which plays an important role in the maintenance of 
health, can become poison if one does not follow 
healthy food habits. The major or primary reasons for 
skin diseases are also faulty habits.  
Shvitra is one of the disease in which colour of 
the skin is changed to Aruna, Tamra or Shveta Varna. 
(1,2) The different causes have been given in the science 
but Viruddha aahar is the unique concept of 
Ayurveda(4), is attributed as one of the cause 
responsible for Shvitra. Charaka and Sushruta are of the 
opinion that disease of recent origin can be cured.(5) 
The symptoms of Shvitra as described in Ayurveda can 
be envisaged in vitiligo, a pigmentation disorder of 
skin. The disease is considered as one of the social evils 
from times immemorial.(3) The science has proved that 
it is only a deformity of the skin pigment and it is not of 
any infective or systemic disease, but it acts as a social 
stigma in the society. Vitiligo is an acquired 
depigmenting skin condition that results from the 
destruction of melanocytes. It affects 3% of the Indian 
population. Although is only cosmetic in nature, it has a 
devastating effect on the psyche of the patient as it 
distorts the body image and causes extreme fear, 
anxiety and concern that is comparable to that 
experienced by a patient with any major illness. The 
disease in India has a special social significance. No 
single theory is above to satisfactorily explain all the 
various types of vitiligo leading one to believe. Vitiligo 
is probably multifactorial in etiology. The large 
majority of patients with this condition have only the 
cosmetic handicap, but there are others that may have 
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systemic association as well.(7,8) As far as the treatment 
remains unsatisfactory to the medical science, attempts 
to improve the results should be continued. 
As effort is done to find out the efficacy of the 
drug ‘Shashilekha Vati’ mentioned in Yogaratnakar(6). It 
contains Shuddha Parada, Shuddha Gamdhaka, Shuddha 
Tamra and Bakuchi kashaya. Parada is Yogavahi. 
According to literary evidence, Gamdhaka is 
recommended as the most effective drug for all skin 
aliments. In ‘Yogaratnakara’, Shashilekha Vati is 
described in the management of Shvitra. Shuddha 
Parada, Shuddha Gamdhaka, Shuddha Tamra are taken 
in equal proportions. These ingredients are mixed 
equally and Mardana process done by Bakuchi kvatha 
for 24 hrs (1 Day). Then are made into tablets of 1 
Gunja (125 mg) each. This formulation is called 
Shashilekha Vati and it is known to treat Shvitra vyadhi. 
This formulation is to be consumed with 1ml of Bakuchi 
taila and 5ml of Madhu. 
AIMS AND OBJECTIVES 
 To develop evidence based support for efficacy of 
textual reference of Yogaratnakara regarding 
Shvitraghna property of Shashilekha Vati with 
Bakuchi tail and Madhu as Anupana. 
 To put forth the adverse reactions if any during the 
therapeutic trials of this drug. 
 To provide effective and non-toxic drug therapy for 
Shvitra. 
CLINICAL STUDY 
Place of Research 
The clinical study was carried out at the dept. of 
Kayachikitsa, Seth Tarachand Ramnath Hospital, Pune. 
Study Design 
 A randomized single blind controlled clinical trial 
was carried out in 60 patients of Shvitra. 
 The inclusion and exclusion criteria used for the 
patients was as follows 
 Study was carried out on patient of both groups for 
a period of minimum 49 days. Follow ups were 
kept on 7th, 14th, 21st, 28th, 35th, 42nd and 49th day. 
Inclusion Criteria 
1. Patients having textual signs and symptoms of 
Shvitra were selected.  
2. Patients suffering from Shvitra were selected 
irrespective of age, sex, education.  
Exclusion Criteria 
1. Albinism 
2. Generalized vitiligo 
3. Cicatrix due to burns though of recent origin. 
4. Skin lesions manifested by leprotic or syphilitic 
origin. 
  
GROUP A GROUP B 
Measures taken to minimize bias 
1) Randomization procedure 
2) Blinding procedure 
1) Randomization Procedure 
Patients were included in individual groups 
randomly. 
Chits of group A and B were made and patients 
were asked to choose one unit. 
2) Blinding Procedure 
Patients were not aware of exact content of the 
drug to be administered. 
Information about blinding was advised to patients 
during pre-trial counseling. 
Dosage Regimen 
Shashilekha Vati is used for drug group. 
Form -  Vati 
Dose -  125 mg. 
Kaala  -  Morning, afternoon, night. 
Duration -  49 days. 
   Route of administration - Oral 
  The original text mentions the dose of this 
tablet as 1 Nishka = 4 Maash = 3.888 gms with 1 Karsha 
= 0.962 Ratti = 11.66 gm Bakuchi tail and Madhu as an 
Anupana. 
  But today, this much of the dosage seems to be 
larger than the needed one. Hence the dose was fixed as 
500 mg ShashilekhaVati three times a day (1500 mg 
daily) with 1 ml. Bakuchi tail and Madhu as an Anupana. 
  But during our pilot study, this much of the 
dose also caused significant gastric irritation and 
itching in those subjects. Hence after discussion with 
the teaching faculty and senior colleagues, it was still 
reduced to 125 mg three times a day with 1 ml of 
Bakuchi tail and Madhu and the same dose was 
continued throughout to study. 
Preparation of study Drug (Shashilekha Vati) 
 Shashilekha Vati was prepared according to the 
method mentioned in the classical text of 
Yogartnakara. 
 Shuddha Parada (Mercury) and Shuddha 
Gandhaka (Sulphur) in equal preparations were 
thoroughly mixed and made into Kajjali. 
 Kajjali was mixed with Shuddha Tamra Bhasma 
taken in equal proportion. 
 Bakuchi kvatha (Kashaya of Psoralia corylifolia) 
was also mixed with the above mentioned 
ingredients and grinding for about 24 hours.  
 This mixture was then dried in a heater. 
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 This dried mixture was then passed through a 
sieve to get granules.  
 These granules were then loaded in the tablet-
making machine to make tables of 1 Gunja (125 
mg) each. (Table 1) 
Table 1: Ingredients of Shashilekha Vati 
Shashilekha Vati 
Ingredients 
Shudha 
Parada 
Shuddha 
Gandhaka 
Tamra 
Bhasma 
Proportion 1 part 1 part 1 part 
Mardan with Bakuchi Kvatha 
Note: Kalmia manna 
1 Karma = 96 Ratti = 1 to1ã = 11.66 gm (metric)  
1 Nishka = 4 Mash = 3.888 gm. (metric) 
Similarly control was used of Yastimadhu vati. Control 
was also administered in the same manner. 
Interim Examination  
Complete history taking and physical 
examination was done on day 0 and on every 7th day 
physical examination related to Shvitra vyadhi was 
done. Final assessment was done on last day (Day 49). 
(Table2)
Table 2: Physical examination patient 
Day Examination 0 7 14 21 28 35 42 49 
Complete physical examination             
Number of lesion         
Measurement of area of lesion         
Colour of lesion         
Primary End Points 
 Change in the colour of lesion  
 Regression in Tvak vaivarnyata e.g. improvement 
in measurement of area of lesion. 
 Commencement of pigmentation, which may be 
marginal, perifollicular, diffuse, combined in 
nature. 
Discontinuation Criteria 
 Incidence of any acute condition or life 
threatening disease. 
 Incidence of any such disease or situation, which 
presents the subject from attending more than 
three interim examinations.  
Procedure of Subject Withdrawal 
 Honorary physicians in Seth Tarachand Ramnath 
offered subjects treatment for their condition. 
 Subject were informed about their withdrawal 
from the trial when their condition were stable 
counseling was done. 
Maintenance of Source Data 
 Special case paper was prepared. 
 Serial number and the group of the patient was 
reordered on the case paper. 
Table 3: Treatment protocol of Patients in Group A and B 
Group Group A Group B 
Treatment given Shashilekha Vati Yastimadhu Vati 
No. of Patients  30 30 
Period 49 Days  49 Days  
Route of administration Oral Oral 
Dosage  125 mg 125 mg 
Dosage scheduled  Morning, afternoon, evening Morning, afternoon, evening 
I) Medications Permitted During Trial  
 Ongoing medications such as anti hypertensive, 
antidiabetic treatment were permitted. 
 In acute condition proper treatment required for 
same. 
Medications not permitted during trial  
 Corticosteroids 
 Analgesics and anti-inflammatory drugs 
 Self medications 
 Ayurvedic internal medication for the same 
disease  
Assessment of Efficacy 
 Efficiency parameters 
 Methods and timing 
Efficacy Parameters 
1. Regimentation 
2. Measurement of area of lesion 
3. Visual Analogue Scale 
The overall effect of the treatment in both the groups 
was assessed. 
Regimentation: The nature of regimentation was 
classification into 4 types: 
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Marginal: When predominant regimentation was from 
the borders of patches. 
Perifollicular: When predominant regimentations was 
follicular. 
Diffuse: When there occurred generalized darkening 
across the patches of vitiligo.  
Combined: If it did not fit into any single type or when 
more than one pattern contributed to the pigmentary 
process. 
Regimentation was recorded as 
Grade  0    -   No change  
Grade  1    -   Minimal change (0 to 25%) 
Grade  2    -   Moderate change (26 to 50%) 
Grade  3    -   Marked change (51 to 75%) 
Grade  4    -   Complete regimentation (76 to 100%) 
Measurement of Area of Lesion 
Measurement of area of the lesion of the skin 
was done. The procedure adapted to measure area is 
delineated here with. The patches were traced on the 
trace paper with the pencil. These tracings were kept 
on graph paper and again these tracing of the patches 
were traced on the graph papers. The total squares of 
the graph paper covered by these tracings were 
counted and the total area was calculated. Those 
square of the graph of which covered less than half size 
of square of graph were not counted. However more 
than half size were counted for one square. Thus up to 
certain extent approximate size of the area was 
calculated.  
The Photographic records of the lesions were kept.  
Visual analogue scale 
Visual Analogue Scale was used to assess two 
parameters mentioned in Ayurvedic texts namely 
kendo and dacha. 
This is an imaginary horizontal line of 10 cm. 
Zero mark on left hand side and 10 on right hand side. 
Zero indicates absolutely no kendo or dacha and ‘10’ 
indicate maximum severe kendo or dacha. Each cm 
indicated points from ‘O’ to ‘10’. Patients were called 
and asked to grade their symptom and define 
accordingly in number before during and after 
treatment. 
The difference between these two points will 
gives rise to the effect of treatment in objective from 
the evaluation of the same was done at the end of the 
trial. 
The score for Visual Analogue Scale. Score  
0 – 1    0 
2 – 4     1 
5 – 7    2 
8 – 10     3 
DISCUSSION 
After observing the observations and analyzing 
the raw data we have come to the conclusion that that 
drug is effective in the conducted trial. The trial was 
conducted on a sample size of 60 divided in two 
groups. In the criteria of assessment, measurement of 
area of lesion, nature of regimentation and degree of 
regimentation were taken. Visual analogue scale was 
used for dacha and kendo. The assessment was carried 
out before and after treatment to evaluate the total 
effect of treatment. 
Discussion about general observations 
1) According to sex 
Female patients were more in number than male 
patients. It may be due to etiological factors like 
Vishmashana, Viruddha Anna, Abhishandi Ahara, 
Vegavarodha and Divasvapa. Hence there is vitiation of 
Tridosha, which leads to Shvitra. 
2) According to Age 
Maximum patients were belonging to Tarunavastha 
group. It may be due to disturbed food habits and 
increasing mental stress day by day in this age group. 
All have led to increase Tridosha giving rise to the 
diseased condition. 
3) According to Occupation 
Students and housewives had more prevalence of 
disease. They have tendency towards Viruddha ahara 
and Vishamashana which causes vitiation of Tridosha 
and cause Shvitra. 
According to family history of Shvitra  
Very few patients gave positive family history of 
Shvitra. 
4) According to diet 
Maximum patients used to take Madhura rasatmaka 
and Snigdha gunatmaka ahara. They also had habit of 
Viruddahara. These factors might have contributed for 
Aamavridhi and subsequent Tridosha prakopa giving 
rise to increased possibility of Shvitra. The incidence of 
vegetarian and non-vegetarian diet was similar. 
5) According to Vihara 
Majority of patients had habit of Divaswapa that is the 
important haut causing kappa and Vata prakopa. 
7) According to Prakriti 
Incidence of Shvitra was predominantly found in 
Kaphapittaja prakriti. 
8) According to Dosha dushti 
Maximum number of patients had vitiation of Tridosha 
in which predominance of kappa dash was found. It 
may be due to the habit of taking the diet dominant in 
Madhura rasa, Snigdha guna in maximum patients. It 
led to vitiation of Kapha. 
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9) According to Dhatu dusty 
Majorities of patients had Rasa, Rate, Mamsa and Meda 
dusty. 
10) According to dacha and Kamdu 
Out of 60 patients, dacha and Kamdu were present in 5 
and 12 patients respectively. 
11) According to Tvakvaivarnyata (colour of lesion) 
All the patients were showed Tvakvaivarnyata 
as Shveta, Rakta or Tamra. Out of 60 patients, 50 had 
Shveta varna, 6 had tama and only 4 patients had 
Raktavarniya tvakvaivarnyata.  
CLINICAL OBSERVATION 
Common etiological factors were seen as 
consumption of Madhura, Snigdha Dravya, Viruddha 
Aahar, Divaswapa etc. 
 Ayurvedic texts clearly mention the bad 
prognosis of chronic Shvitra and very good prognosis if 
treated in early stages, same thing is found in my 
research project. The patients who have consulted in 
early stage of the disease obtained good result 
comparatively to chronic patients. From this 
observation it can be stated that early consultation 
gives good result in Shvitra vyadhi. 
It is observed that there is significant 
regimentation in the treated lesion and reduction in 
total area of lesions.  
Shashilekha Vati with Anupana enters to all 
Sukshmastrotasas and it acts on dash, Dhatu by 
properties of Sukshma, Tikshna guna and Ushna virya. 
Thus it does Diana, patina and acts as Tvacya, Varna. 
Oil of Bakuci acts on arterioles of sub capillary 
plexus due to which they dilate and increase the plasma 
in this area. At the same time copper acts on enzyme 
tyrosine’s. Due to which melanoblasts are stimulated. 
They further exude and diffuse into the decolourised 
area and pigmentation takes place in that area. 
In this way, Shashilekha Vati acts as Tvachya, 
Varnya and Shvitraghna. 
Control group showed very poor result as 
compared to the treated group. 
It is observed that out of 30 patients in Drug 
Group i.e. taking Shashilekha Vati, 19 patients had 
marked to complete (76-100%) regimentation, 7 
patients had marked (51-75%) regimentation, 3 
patients had moderate (26-50%) regimentation and 
only one patient had minimal (below 25%) 
regimentation. 
In Control Group, out of 30 patients, 2 patients 
had moderate regimentation, 10 patients had minimal 
regimentation and 18 patients had no regimentation. 
Out of 30 patients in Drug Group, 10 patients 
had perifollicular type and 3 patients had combined 
type of regimentation. Maximum number of patients i.e. 
17 patients had diffuses type of regimentation. 
Shvitra is a Tridoshaja vyadhi which 
predominantly involves Tvakgata lasika, rate and 
Mamsa dhatu. It also involves Udana vayu, Ranjaka pita 
and Bhrajaka pita. 
All ingredients of Shashilekha Vati are 
Kaphavatashamaka by virtue of their Katutikta rasa, 
Katu vipaka and Ushna virya. All of these contents 
specifically act as Kushtaghna by their Prabhava. 
Gandhaka and Bakuchi being Katutikta rasa, 
Kato Vipaka and Ushna virya act as Aamapacaka by 
Agnidipana. Tamra scrapes out the stuck Aama, in 
various Strotasaas. It also acts as Vatashamaka by 
Madhura vipaka. So, it helps Dana vatu to function 
properly. Parada by virtue of its Ramayana, Yogavahi 
and Kushtaghna property has an ability to reach all 
Sukshmatisukshma strotasas All these factors 
contribute for Agnivardhana and hence proper 
functioning of Pacaka pita. Thus good quality of 
Ahararasa is produced which intern helps further 
Dhatu to achieve the expected Nirama avastha. Due to 
which, functioning of Raktadhatvagni gets regulated, 
proper Raktaprasadana is done. It helps remake and 
Bhrajaka pita to function properly and giving rise to a 
normal colour and luster to skin respectively. As a drop 
of oil spreads instantaneously in water, Anupana helps 
the drug to spreads all over the body. To increase the 
potency of drug specific Anupana is advised. Bakuci 
taila is an extract of their seeds, it has a property of 
Katu rasa and Ushna virya and it acts as 
Vyadhipratyanika Dravya by Prabhava. Madhu is a 
Yogavahi and Suksmastrotogami. Shvitra is 
predominantly a disease of Tvacha and Tvacha covers 
all the body. Taila and Madhu helps all ingredients of 
Vati to reach all the Strotasas and Dhatu. Taila also acts 
as Agnidipana by Katu rasa and Ushna virya. 
Shashilekha Vati enters to all minute Strotasa 
and it acts on all dash, Dhatu by properties of Sukshma, 
Tikshna guna and Ushna virya. Thus, it does Dipana, 
Pachana and acts as Tvachya, Varnya, Shvitraghna. 
Shashilekha Vati is very useful in the treatment of 
Shvitra. 
RESULTS 
 According to classification of degree of 
regimentation stated by ‘American Journal of 
Dermatology’, ‘t’ value calculated for comparison 
between ‘Group A’ and ‘Group B’ is t cal = 12.14, 
which is greater than ‘t’ value of ‘t’ table which is 
significant. Thus degree of regimentation in Group 
A (P=0.0027<0.05) is statistically significant as 
compared to Group B (P=0.45>0.05). 
 ‘P’ value calculated for comparison between ‘Group 
A’ and ‘Group B’ for decrease in area of lesion is 
0.0076<0.05, which is statistically significant. Thus, 
statistically it is proven that there is significant 
decrease in area of lesion in ‘Group A’ over ‘Group 
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B’. Hence, in Group A, significant positive effects 
were seen such as commencement of pigmentation 
and decrease in area of lesion as compared to 
Group B.  
This means, the drug used i.e. Shashilekha Vati’ 
is significant as compared to ‘Yashtimadhu Vati’. Thus, 
efficacy of Shashilekha Vati’ by textual method is 
proved.  
 CONCLUSION 
 After analyzing all the raw data and observations, 
we come to conclusion that the Drug Group A-
Shashilekha vati showed significant regimentation 
and reduction in area of lesions as compared to 
Group B. Thus it is found that Group A is highly 
significant against Group B. 
 Shashilekha Vati is statistically significant in 
Shvitra vyadhi. 
 Shashilekha Vati showed dominantly diffuse type 
of regimentation.  
 After achieving satisfactory regimentation in 
Shvitra, it is also important to look for its stability 
in future. The further study regarding the ability 
of the drug to retain the pigment is necessary. 
Hence the topic is open to eminent scholars for 
the further study and evaluation.  
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